0001179110-17-010601.txt : 20170721 0001179110-17-010601.hdr.sgml : 20170721 20170721162243 ACCESSION NUMBER: 0001179110-17-010601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwicki Mark T CENTRAL INDEX KEY: 0001415537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 17976804 MAIL ADDRESS: STREET 1: 84 WATERFORD DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 edgar.xml FORM 4 - X0306 4 2017-07-19 0 0001479419 Kala Pharmaceuticals, Inc. KALA 0001415537 Iwicki Mark T C/O KALA PHARMACEUTICALS, INC. 100 BEAVER STREET, SUITE 201 WALTHAM MA 02453 1 1 1 0 Chief Executive Officer Stock Option (right to buy) 15 2017-07-19 4 A 0 78632 0 A 2027-07-18 Common Stock 78632 78632 D This option was granted, effective on July 19, 2017 and vests over four years, with 2.0833% of the shares underlying the option vesting on August 31, 2017 and an additional 2.0833% of the shares vesting at the end of each successive one-month period thereafter. /s/ Mary Reumuth, Attorney-in-Fact 2017-07-21